Experimental data indicated that P4HA3 facilitated GC cell proliferation, migration and invasion, and enhanced glycolytic activity and increased the expression of key glycolysis-related proteins, suggesting that P4HA3 may induce a broader metabolic activation rather than an exclusively glycolytic shift.
Tao Wang, Xiao Xu, C. Jin et al.· Pakistan Journal of Pharmace...· 0 citations
Findings reveal a potential RNF113A/SNIP1/TGF-β regulatory axis and highlight RNF113A as a potential therapeutic target in CRC, warranting further mechanistic validation.
Kao-Yan Feng, Meng-Bin Qin, Peng Peng et al.· Balkan Medical Journal· 0 citations
It is revealed that circARHGAP10 functions as a tumor suppressor in CRC via two independent regulatory branches downstream of the circARHGAP10/miR-29a-5p cascade, and this newly identified circRNA-centered regulatory network provides a promising novel therapeutic target for CRC intervention.
Li-Yuan Liu, Yong-Cun Jia, Dong-Jie Li et al.· Molecular and Cellular Bioch...· 0 citations
Colorectal cancer (CRC) is a common cause of cancer-related deaths worldwide. Electron transfer flavoprotein dehydrogenase (ETFDH) is a novel prognostic biomarker for human CRC. However, the role and molecular mechanism of ETFDH in CRC are still unclear. DEGs in CRC development were identified using mRNA microarray dat...
Yan Zeng, Qiao-Zhen Liu, Ya-Li Xu et al.· General Physiology and Bioph...· 0 citations
Silencing of TMEM33 markedly suppresses CRC cell proliferation, migration, invasion, and epithelial-mesenchymal transition (EMT) both in vitro and in vivo, and significantly reduces subcutaneous tumor growth and pulmonary metastatic burden.
Rui Li, Li Zhao, Nan-Nan Chai et al.· Human Cell· 0 citations